Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

Iowa lawmakers introduce bills to stop Pharmacy Benefit Managers from giving pharmacies less money than it costs to fill prescriptions.

GRAND JUNCTION, Colo. (KJCT) -A bipartisan bill was introduced into the house this week regarding healthcare costs for Coloradans. The bill introduced by Representatives Kyle Brown and Dusty Johnson ...

Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...

Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.

Cigna executives kicked off Thursday’s earnings call by responding to pharmacy benefit manager critics with a number of reforms.

At the Senate Finance nomination hearing yesterday, he declined to give a yes-or-no answer about Affordable Care Act tax credit rule renewal.

According to Bloomberg, a top Cigna executive said it will prevent patients from paying the full list price for drugs, or more than their employer has contributed.

Mentioning advances in AI and telemedicine, Kennedy highlighted the opportunity to make breakthroughs in healthcare.

President Trump's nominee for health secretary, Robert F. Kennedy Jr., was questioned harshly by both Democrats and ...

The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...